The following is an excerpt of a NPR Blog article that was shared in the February 2015 issue of The Guardian of Public Health
The first 12 volunteers received an experimental Ebola vaccine in Liberia, launching vaccine trials there. Over the next year or so, scientists hope to inject 27,000 volunteers. The goal is to test two different shots that could protect people from the deadly disease. But the number of Ebola cases is steadily declining across West Africa. And that good news is hampering drug and vaccine development, especially in Liberia.
Posts on this page are compiled from information Region 7 receives form partners and related news media resources.